Search research articles
Contact Us
Filters
Showing results (331-340 of 391) with videos related to
Page
of 40
Sort By:
Plos One
|
October 20, 2022
Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology
Nikhil Mayor, Harry Knights, Aleksandra Kotwica, et al.
Cancer Medicine
|
August 8, 2023
Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding
Holly G Prigerson, David Russell, Sophia E Kakarala, et al.
Pain Reports
|
March 13, 2026
Analgesic strategies for ischaemic pain in chronic limb-threatening ischaemia: a systematic review and meta-analysis
Henry Davies, Ahmed Boalot, Annabel Howitt, et al.
Physiological Reports
|
April 4, 2018
Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans
Camilla Pedersen, Umer Z Ijaz, Edith Gallagher, et al.
Future Oncology (London, England)
|
April 25, 2025
Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?
Daniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
BJU International
|
July 31, 2025
Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide
Nicole Handa, Neal D Shore, Matthew R Cooperberg, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Daniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
Plos One
|
January 9, 2014
Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis
Azhar Abbas, Pål Aukrust, David Russell, et al.
Diabetes Care
|
March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)
David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
Journal of Neurology
|
June 1, 2012
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics
Claudio Baracchini, José M Valdueza, Massimo Del Sette, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 391) with videos related to
Sort By:
Page
of 40
Plos One
|
October 20, 2022
Intrapulmonary shunting is a key contributor to hypoxia in COVID-19: An update on the pathophysiology
Nikhil Mayor, Harry Knights, Aleksandra Kotwica, et al.
Cancer Medicine
|
August 8, 2023
Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understanding
Holly G Prigerson, David Russell, Sophia E Kakarala, et al.
Pain Reports
|
March 13, 2026
Analgesic strategies for ischaemic pain in chronic limb-threatening ischaemia: a systematic review and meta-analysis
Henry Davies, Ahmed Boalot, Annabel Howitt, et al.
Physiological Reports
|
April 4, 2018
Fecal Enterobacteriales enrichment is associated with increased in vivo intestinal permeability in humans
Camilla Pedersen, Umer Z Ijaz, Edith Gallagher, et al.
Future Oncology (London, England)
|
April 25, 2025
Plain language summary: does race or income status affect the cancer treatments that patients with metastatic castration-sensitive prostate cancer (mCSPC) receive in the United States?
Daniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
BJU International
|
July 31, 2025
Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide
Nicole Handa, Neal D Shore, Matthew R Cooperberg, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2024
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Daniel J George, Neeraj Agarwal, Krishnan Ramaswamy, et al.
Plos One
|
January 9, 2014
Matrix metalloproteinase 7 is associated with symptomatic lesions and adverse events in patients with carotid atherosclerosis
Azhar Abbas, Pål Aukrust, David Russell, et al.
Diabetes Care
|
March 31, 2017
Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1)
David Russell-Jones, Bruce W Bode, Christophe De Block, et al.
Journal of Neurology
|
June 1, 2012
CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics
Claudio Baracchini, José M Valdueza, Massimo Del Sette, et al.
Page
of 40